Seoul National University Bundang Hospital,
Seongnam-si, Gyeonggi-do, 13620, South Korea
NCT Number: NCT03928613
The purpose of this study is to examine therapeutic efficacy of cognitive Training based on location information and activity in people with mild cognitive impairment
Looking for future studies?
Notify Me60 year and older
All sexes
Interventional
Not applicable
Seongnam-si, Gyeonggi-do, 13620, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants perform Tablet based Cognitive training using interactive voice services and tags three times (minimum 30 minutes per time) a week for 6 weeks
Time frame: baseline and 6 weeks
Total Score of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Neuropsychological Assessment Battery (CERAD-TS1) . CERAD-TS1 is generated by simply summing the scores of six tests including the 1) Verbal fluency (range 0-24), 2) Boston naming test (0-15), 3) Word List Memory (0-30), 4) Word List Recall (0-10), 5) Word list recognition (0-10), 6) Constructional Praxis (0-11). The range of CERAD-TS1 score is 0 to 100 points), and the higher score represents the better cognitive function.
Time frame: baseline and 6 weeks
Mini-Mental State Examination (MMSE), ranged 0-30, the higher score represents the better cognitive function
Time frame: baseline and 6 weeks
Subjective Memory Complaint Questionnaire (SMCQ), ranged 0-14, the higher score represents the more difficulties in memory function for everyday life
Time frame: baseline and 6 weeks
Geriatric depression scale (GDS), ranged 0-30, the higher score represents the more severe depressive symptoms
Seoul National University Bundang Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06347172
Alzheimer Disease, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT04070703
Cognition Disorders, Cognitive Dysfunction
Eugene, Oregon, United States
View Trial DetailsNCT07554144
Adolescent Development, Attention Impaired
Kütahya, Centre, Turkey (Türkiye)
View Trial DetailsNCT07729865
Cognition Disorders, Cognitive Dysfunction
Lahore, Punjab Province, Pakistan
View Trial Details